The incidence of atopic dermatitis, a chronic inflammatory skin disease, in both adults and children is still high. An altered microbiota appears to be among the risk factors.
Dermobiotics innovation is targeted to keep the perfect balance for the skin microbiota survival. By working on Microbiota research, ROELMI HPC developed the most outstanding ingredient to maintain eubiosis in order to achieve skin health.
The sustainable profile of finished formulas could not miss the selection of the inner compounds completing the cosmetic recipe in which the “eco-friendly” feature is of paramount importance and driven by innovation and inspired by a more equitable, inclusive and sustainable model of production.
Celus-Bi® Feel, represents one of the latest results in R&D towards innovation in texturizers. With proved performances against standardplasticizing powders and peculiar environmental-friendly impact (readily biodegradable according to OECD 301 method), it represents an efficient and valid alternative to formulate sustainable cosmetics, by maintaining or improving, all the technical cosmetic performances but replacing standard powders like [...]
SelectSIEVE® Rainbow: A multifunctional solution for natural body shaping and beauty from within.
Women embrace changes during all stages of life. Hormonal changes affect all parts of the body; they can deeply modify the vaginal environment, and in some cases lead to infections, linked to poor vaginal biodiversity.
ROELMI HPC is very proud to have been selected as one of the Leaders of Sustainability for 2021 by Il Sole 24 Ore.
Nutricosmetics versatility meets customer’s renewed awareness and its “new normal”, now oriented to prevention and tangible results over-time.
Starting from a great innovation of Nature, ROELMI HPC has standardized and industrialized the production of a specific molecule by fermentation thereby obtaining a balancer of the skin microenvironment that allows an equilibrium of skin microbiota living in specific sites.
ROELMI HPC expert of probiotic ingredients, has designed and developed a probiotic complex that, showed to be a valid support in reducing the risk linked to the development of CVDs.